Histamine increases lung permeability by an H2-receptor mechanism

Lancet. 1984 Aug 18;2(8399):372-4. doi: 10.1016/s0140-6736(84)90542-7.

Abstract

The effect of specific H1 and H2 receptor antagonists on bronchial reactivity and increase in lung epithelial permeability in response to inhaled histamine was measured in 5 non-smoking men (age range 24-36 years). Inhaled histamine produced a short-lived but consistent increase in permeability to 99Tc-diethylenetriamine penta-acetate. An H1-receptor antagonist, terfenadine (60 mg), protected against the bronchoconstrictor effect but had no significant influence on the increase in permeability. The H2-receptor antagonist ranitidine (150 mg) significantly reduced the permeability response without having an effect on bronchial reactivity. These results demonstrate that the bronchoconstrictor effect of histamine is mediated by H1 receptors and permeability increase is mediated by H2 receptors. H2-receptor mediated increase in lung epithelial permeability may be important clinically.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Benzhydryl Compounds / pharmacology
  • Bronchi / drug effects
  • Bronchi / physiology
  • Bronchial Provocation Tests
  • Double-Blind Method
  • Epithelium / physiology
  • Histamine / pharmacology*
  • Histamine H1 Antagonists / pharmacology
  • Humans
  • Lung / drug effects
  • Lung / physiology*
  • Male
  • Permeability
  • Ranitidine / pharmacology
  • Receptors, Histamine / physiology*
  • Receptors, Histamine H2 / drug effects
  • Receptors, Histamine H2 / physiology*
  • Terfenadine

Substances

  • Benzhydryl Compounds
  • Histamine H1 Antagonists
  • Receptors, Histamine
  • Receptors, Histamine H2
  • Terfenadine
  • Histamine
  • Ranitidine